Nordea Investment Management AB / TMO
Nordea Investment Management AB’s Thermo Fisher Scientific Inc Position
Does Nordea Investment Management AB own Thermo Fisher Scientific Inc (TMO)? Yes — 39.0K shares worth $19M (+0.02% of its 13F portfolio) as of Q1 2026, down from 90.5K shares the prior filed quarter.
Position Value
$19M
Q1 2026
Shares
39.0K
% of Portfolio
+0.02%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 39.0K | $19M | +0.02% |
| Q4 2025 | 90.5K | $53M | +0.05% |
| Q3 2025 | 177.1K | $82M | +0.07% |
| Q2 2025 | 63.2K | $26M | +0.02% |
| Q1 2025 | 59.7K | $29M | +0.03% |
| Q4 2024 | 55.5K | $29M | +0.03% |
| Q3 2024 | 44.8K | $28M | +0.03% |
| Q2 2024 | 71.8K | $40M | +0.05% |
| Q1 2024 | 69.9K | $40M | +0.05% |
| Q4 2023 | 262.9K | $140M | +0.18% |
| Q3 2023 | 528.4K | $268M | +0.37% |
| Q2 2023 | 692.6K | $360M | +0.49% |
| Q1 2023 | 682.1K | $389M | +0.57% |
| Q4 2022 | 687.4K | $377M | +0.59% |
| Q3 2022 | 723.8K | $373M | +0.60% |
| Q2 2022 | 726.2K | $388M | +0.58% |
| Q1 2022 | 758.6K | $454M | +0.57% |
| Q4 2021 | 742.9K | $496M | +0.59% |
| Q3 2021 | 737.7K | $433M | +0.56% |
| Q2 2021 | 719.6K | $363M | +0.49% |
| Q1 2021 | 953.0K | $434M | +0.63% |
| Q4 2020 | 849.6K | $396M | +0.64% |
| Q3 2020 | 789.8K | $347M | +0.65% |
| Q2 2020 | 1.40M | $494M | +0.51% |
| Q1 2020 | 659.0K | $186M | +0.45% |
| Q4 2019 | 399.1K | $130M | +0.26% |
| Q3 2019 | 316.8K | $92M | +0.20% |
| Q2 2019 | 294.5K | $87M | +0.19% |
| Q1 2019 | 281.3K | $77M | +0.16% |
| Q4 2018 | 986.0K | $221M | +0.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nordea Investment Management AB’s full portfolio or all institutional holders of TMO.